Covington & Burling LLP

This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

PDF Binder
- Create PDF
- Add to Binder
Word Document Binder

Mingham Ji

Associate

Washington +1 202 662 5621 mji@cov.com Download V-card

View Less

Mingham Ji is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Anti-Corruption practice groups. Ms. Ji advises food, dietary supplement, pharmaceutical, and biotechnology companies on regulatory and compliance issues. She is also a regular contributor to the InsideMedicalDevices blog.

Counsel multinational food company in its responses to inquiries about its products from FDA, Congress, and local and foreign governments.
Assisted biotechnology company and trade organization in drafting comments on FDA draft guidance for biosimilars.
Assisted pharmaceutical company in drafting citizen petition to FDA on therapeutic equivalence rating for generic version of an innovator product.
Advise food and dietary supplement companies on compliance with FDA’s labeling requirements.
Advise pharmaceutical companies on anti-kickback and related fraud and abuse issues.
Conduct anti-corruption due diligence of life sciences companies.

Provide legal information on landlord/tenant issues through the DC Bar Pro Bono Program’s Landlord-Tenant Resource Center.

FDA Finalizes General Wellness Guidance

In a new post on Covington’s InsideMedicalDevices blog, we provide an analysis of FDA’s newly issued final guidance document entitled “General Wellness: Policy for Low Risk Devices.” To read the post, please click here.… Continue Reading

Covington Advises Salix in $2.6 Billion Acquisition of Santarus

WASHINGTON, DC, November 7, 2013 — Salix Pharmaceuticals, Ltd., and Santarus, Inc. announced today that the companies have entered into a merger agreement where Salix will acquire all of the outstanding stock of Santarus for $32 in cash per share, for a total value of approximately $2.6 billion. Covington & Burling LLP is advising Salix on both the acquisition ...

FDA Updates Draft Guidance on Medical Foods

View More View Less

Education

The University of Chicago Law School, J.D., 2012

The University of Chicago Legal Forum, Articles Editor

Amherst College, B.A., 2009

summa cum laude
Stephen E. Whicher Prize
John Woodruff Simpson Fellowship

Representative Matters

Pro Bono

News and Insights (Showing 5 of 21) (Showing 21 of 21)

FDA Finalizes General Wellness Guidance

FDA Publishes Final Rule on Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption

CFDA Accelerates Implementation of Drug Electronic Monitoring Network

FDA Finalizes the Rule Prohibiting Most Omega-3 Nutrient Content Claims

FDA Publishes Proposed Rules on Changes to Nutrition Labels

FSMA Deadlines Extended as FDA Reaches Settlement in Litigation

FDA Publishes Proposed Rule on Sanitary Transportation of Human and Animal Food Under FSMA

FDA Issues Guidance Documents Relating to Liquid Dietary Supplements and Substances Added to Foods

CFDA Releases New Proposed Rule on Drug Contract Manufacturing for Public Comment

CFDA Releases Draft Revision of Primary Drug Approval Regulation

CFDA Publishes Notice on Mandatory Clinical Trial Disclosures

Covington Advises Salix in $2.6 Billion Acquisition of Santarus

FDA Releases Proposed Rule to Establish Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals

FDA Holds Public Meeting on FSMA Proposed Rules for Foreign Supplier Verification Programs and Accreditation of Third-Party Auditors/Certification Bodies

China's 1st Step Toward More Participation In Rulemaking

CFDA Publishes Draft Rule on Administrative Procedure for Public Comment

FDA Updates Draft Guidance on Medical Foods

SEC Charges China-Based RINO International and Senior Executives with Fraud-Related Violations of Federal Securities Laws

China Reorganizes the SFDA and Appoints a New Commissioner

Keyuan Petrochemicals and Former Senior Executive Pay Over $1 Million to Settle China-Related FCPA Allegations Brought by the SEC

FDA Releases Proposed Rule for Produce Safety Under FSMA

Practices

Industries

Education

The University of Chicago Law School, J.D., 2012

Amherst College, B.A., 2009

Bar Admissions

Languages